1. Home
  2. TENX vs COPR Comparison

TENX vs COPR Comparison

Compare TENX & COPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.72

Market Cap

74.1M

Sector

Health Care

ML Signal

N/A

Logo Idaho Copper Corporation Common Stock

COPR

Idaho Copper Corporation Common Stock

N/A

Current Price

$1.99

Market Cap

60.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
COPR
Founded
1967
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
60.1M
IPO Year
2001
2008

Fundamental Metrics

Financial Performance
Metric
TENX
COPR
Price
$1.72
$1.99
Analyst Decision
Buy
Analyst Count
10
0
Target Price
★ $9.63
N/A
AVG Volume (30 Days)
★ 2.0M
71.5K
Earning Date
11-11-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $609,174.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.31
$1.90
52 Week High
$19.40
$4.16

Technical Indicators

Market Signals
Indicator
TENX
COPR
Relative Strength Index (RSI) 42.67 23.05
Support Level $1.34 N/A
Resistance Level $2.00 $3.63
Average True Range (ATR) 0.12 0.29
MACD 0.09 -0.10
Stochastic Oscillator 70.91 6.17

Price Performance

Historical Comparison
TENX
COPR

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About COPR Idaho Copper Corporation Common Stock

Idaho Copper Corp is a USA-based company focused on exploring and developing its copper-molybdenum-silver deposit in Idaho, known as the CuMo project. The CuMo project currently consists of several federal unpatented lode mining claims and various patented mining claims. The unpatented lode mining claims and patented claims are situated in an unorganized mining district, in Boise County, Idaho, spanning Sections in Township 7N and 8N, Range 5E and 6E, Boise Meridian.

Share on Social Networks: